Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

121.32 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,889
Open 121.32
Bid (Size) 121.00 (2)
Ask (Size) 121.25 (2)
Prev. Close 121.32
Today's Range 121.32 - 121.32
52wk Range 62.55 - 170.47
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected by Sept. 
Via Benzinga
Exposures COVID-19
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
These biotech stocks have promising outlooks that will bring major fortune to investors. Buy before it is too late. 
Via InvestorPlace

Performance

YTD
+7.84%
+7.84%
1 Month
-8.97%
-8.97%
3 Month
+18.94%
+18.94%
6 Month
+22.46%
+22.46%
1 Year
-3.08%
-3.08%

More News

Read More
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
Via Benzinga
Exposures COVID-19
3 Biotech Stocks to Buy in Case of Another Pandemic
Via InvestorPlace
Is Moderna Stock a Buy?
Via The Motley Fool
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
Via Benzinga
Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling
Via Benzinga
2 Growth Stocks Down 25% to Buy Right Now
Via The Motley Fool
Health Officials Keep Close Eye On Bird Flu As It Infects Cows For The First Time
Via Benzinga
3 Pharma Stocks That Could Make Your Grandchildren Rich
Via InvestorPlace
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
Via ACCESSWIRE
Moderna To Collaborate With Mitsubishi On Respiratory Vaccine Promotion In Japan
Via Benzinga
Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines
Via ACCESSWIRE
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
3 Biotech Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
Via InvestorPlace
AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's Going On With Moderna Stock Wednesday
Via Benzinga
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
Via Benzinga
Exposures COVID-19
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Via MarketBeat
Topics ETFs
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.